Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility study.

Jessica MoeKatherin BadkeMegan PrattRaymond Y ChoPouya AzarHeather FlemmingK Anne SutherlandBarbara HarveyLara GurneyJulie LockingtonPenny BrasherSam GillEmma GarrodMisty BathAndy Kestler

Published in: Journal of the American College of Emergency Physicians open (2020)

ED-initiated take-home standard-dosing and microdosing buprenorphine/naloxone programs are feasible, and a randomized controlled trial would be acceptable to our target population.

Keyphrases

emergency department
healthcare
public health
adverse drug